Biogen Alzheimer’s drug and the battle over dementia treatment of the future

Biogen Alzheimer's drug Aduhelm is the first new treatment for dementia approved by the FDA in decades, and it's started a war over the brain drug pipeline.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.